Skip to main content
Log in

Is the Use of Fullerene in Photodynamic Therapy Effective for Atherosclerosis?

  • Laboratory Investigation
  • Published:
CardioVascular and Interventional Radiology Aims and scope Submit manuscript

Abstract

The purpose of this study was to evaluate Fullerene as a therapeutic photosensitizer in the treatment of atherosclerosis. An atherosclerotic experimental rabbit model was prepared by causing intimal injury to bilateral external iliac arteries using balloon expansion. In four atherosclerotic rabbits and one normal rabbit, polyethylene glycol-modified Fullerene (Fullerene-PEG) was infused into the left external iliac artery and illuminated by light emitting diode (LED), while the right external iliac artery was only illuminated by LED. Two weeks later, the histological findings for each iliac artery were evaluated quantitatively and comparisons were made among atherosclerotic Fullerene+LED artery (= 4), atherosclerotic light artery (= 4), normal Fullerene+LED artery (= 1), and normal light artery (= 1). An additional two atherosclerotic rabbits were studied by fluorescence microscopy, after Fullerene-PEG-Cy5 complex infusion into the left external iliac artery, for evaluation of Fullerene-PEG incorporated within the atherosclerotic lesions. The degree of atherosclerosis in the atherosclerotic Fullerene+LED artery was significantly (< 0.05) more severe than that in the atherosclerotic LED artery. No pathological change was observed in normal Fullerene+LED and LED arteries. In addition, strong accumulation of Fullerene-PEG-Cy5 complex within the plaque of the left iliac artery of the two rabbits was demonstrated, in contrast to no accumulation in the right iliac artery. We conclude that infusion of a high concentration of Fullerene-PEG followed by photo-illumination resulted not in a suppression of atherosclerosis but in a progression of atherosclerosis in experimental rabbit models. However, this intervention showed no adverse effects on the normal iliac artery.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Spears JR, Serur J, Shropshire D, Paulin S (1983) Fluorescence of experimental atheromatous plaques with hematoporphyrin derivative. J Clin Invest 71:395–399

    Article  PubMed  CAS  Google Scholar 

  2. Spokojny AM, Serur JR, Skillman J, Spears JR (1986) Uptake of hematoporphyrin derivative by atheromatous plaques: studies in human in vitro and rabbit in vivo. J Am Coll Cardiol 8:1387–1392

    Article  PubMed  CAS  Google Scholar 

  3. Rockson SG, Kramer P, Razavi M, Szuba A, Filardo S, Fitzgerald P, Cooke JP, Yousuf S, DeVault AR, Renschler MF, Adelman DC (2000) Photoangioplasty for human peripheral atherosclerosis. Results of phase I trial of photodynamic therapy with motexafin lutetium (Antrin). Circulation 102:2322–2324

    PubMed  CAS  Google Scholar 

  4. Usui M, Asahara T, Naitoh Y, Katoh T, Ibukiyama C (1999) Photodynamic therapy for the prevention of intimal hyperplasia in balloon-injured rabbit arteries. Jpn Circ 63:387–393

    Article  CAS  Google Scholar 

  5. Bayes-Genis A, Conover CA, Schwartz RS (2000) The insulin-like growth factor axis. A review of atherosclerosis and restenosis. Circ Res 86:125–130

    PubMed  CAS  Google Scholar 

  6. Tabata Y, Murakami Y, Ikada Y (1997) Photodynamic effect of polyethylene glycol-modified Fullerene on tumor. Jpn J Cancer Res 88:1108–1116

    PubMed  CAS  Google Scholar 

  7. Svaasand LO (1984) Optical dosimetry for direct and interstitial photoradiation therapy of malignant tumors. Prog Clin Res 170:91–114

    CAS  Google Scholar 

  8. Dougherty TJ, Copper MT, Mang TS (1990) Cutaneous phototoxic occurrences in patients receiving Photofrin. Lasers Surg Med 10:485–488

    Article  PubMed  CAS  Google Scholar 

  9. Hayase M, Woodbum KW, Perlroth J, Miller RA, Baumgardner W, Yock PG, Yeung A (2001) Photoangioplasty with local motexafin lutetium delivery reduces macrophages in a rabbit post-balloon injury model. Cardiovasc Res 49:449–455

    Article  PubMed  CAS  Google Scholar 

  10. Stary HC, Chandler AB, Dinsmore RE, Fuster V, Glagov S, Insull W Jr, Rosenfeld ME, Schwartz CJ, Wagner WD, Wissler RW (1995) A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. Circulation 92:1355–1374

    PubMed  CAS  Google Scholar 

  11. Murakoshi N, Miyauchi T, Kakinuma Y, Ohuchi T, Goto K, Yanagisawa M, Yamaguchi I (2002) Vascular endothelin-B receptor system in vivo plays a favorable inhibitory role in vascular remodeling after injury revealed by endothelin-B receptor-knockout mice. Circulation 106:1991–1998

    Article  PubMed  CAS  Google Scholar 

  12. Singh U, Jialal I (2006) Oxidative stress and atherosclerosis. Pathophysiology 13:129–142

    Article  PubMed  CAS  Google Scholar 

  13. Yung LM, Leung FP, Yao X, Chen ZY, Huang Y (2006) Reactive oxygen species in vascular wall. Cardiovasc Hematol Disord Drug Targets 6:1–19

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Norihisa Nitta.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nitta, N., Seko, A., Sonoda, A. et al. Is the Use of Fullerene in Photodynamic Therapy Effective for Atherosclerosis?. Cardiovasc Intervent Radiol 31, 359–366 (2008). https://doi.org/10.1007/s00270-007-9238-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00270-007-9238-8

Keywords

Navigation